Combination of low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical hodgkin lymphoma (rrhl), 5-year experience from tata memorial centre

Combination of low-dose nivolumab and bendamustine in children with high-risk relapsed/refractory classical hodgkin lymphoma (rrhl), 5-year experience from tata memorial centre

Saved in:
Bibliographic Details
Main Authors: Aditya Narayan, Shyam Srinivasan, Poonam Khemani, Nidhi Dhariwal, Akanksha Chichra, Chetan Dhamne, Nirmalya Roy Moulik, Gaurav Narula, Sneha Shah, Tanuja Seth, VikramjitKhanwar, Shripad Banavalli
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Pediatric Hematology Oncology Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S2468124524003565
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468124524003565

Similar Items